Fentora is a powerful narcotic approved by the Food and Drug Administration to treat acute pain associated with cancer. It was approved for a very specific use only.
It has only been on the market since approval in October of 2006. Since that time, it is estimated that over 78,000 prescriptions have been written, according to the manufacturer, Cephalon.

Several deaths have been linked to the use of Fentora in patients who were prescribed the drug to treat ailments other than cancer. According to the manufacturer, there were four reported deaths associated with Fentora, three of which were related to off label uses. Two of these patients appear to have been prescribed Fentora to treat headaches.

Off label use refers to when a physician prescribes a drug for non-approved uses. Off label prescribing can be dangerous, especially with potent drugs like Fentora which have a high potential for abuse and may result in death for those who overdose on it.

Fentora contains fentanyl, a highly addictive substance that is much more powerful than  morphine, a commonly used medication.

The FDA issued a General Advisory, a Public Health Advisory and a Healthcare Professional Alert concerning Fentora in September of this year. These came after the manufacturer had issued Dear Doctor and Healthcare Professional letters earlier in the month. These letters stressed that the medication should only be used for its indicated purpose.

If you or a loved one has taken Fentora and has been injured, please fill out and submit our confidential questionnaire or contact attorney William Bross by email at wlbross@hgdlawfirm.com, or phone Heninger Garrison Davis at 1-800-241-9779.